GEMFIBROZIL

Generic: GEMFIBROZIL

Cadila Pharmaceuticals LimitedManufacturer
ORALRoute
GEMFIBROZILActive Substance
2016-06-17Original Approval

GEMFIBROZIL is FDA application ANDA203266, sponsored by CADILA PHARMS LTD. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
NAUSEA
649 reports
2
FATIGUE
621 reports
3
DRUG INEFFECTIVE
598 reports
4
DIARRHOEA
553 reports
5
PAIN
504 reports
6
RHABDOMYOLYSIS
471 reports
7
ASTHENIA
457 reports
8
DIZZINESS
448 reports
9
RENAL FAILURE
440 reports
10
DYSPNOEA
438 reports